Ingrid Mueller-Fleckenstein

Title: The Innovations of Ingrid Mueller-Fleckenstein

Introduction

Ingrid Mueller-Fleckenstein is a notable inventor based in Wiesenthau, Germany. She has made significant contributions to the field of immunology, particularly in the transformation of human T-lymphocytes. Her work has implications for both research and therapeutic applications.

Latest Patents

Ingrid holds a patent for the invention titled "Stable growth transformation of human T-lymphocytes by Herpesvirus." This invention focuses on the transformation of human T-lymphocytes to stable growth by infecting these T-cells with strains of H. saimiri subgroup NonA NonB, preferably subgroup C. The transformed cells can grow independently of antigen stimulation and exhibit a phenotype of activated mature T-lymphocytes. They express cell surface markers characteristic of the distinct differentiation status of the T-cells. This method can be utilized to generate human T-cell lines for various immunological and biochemical applications, as well as for therapeutic use. She has 1 patent in her name.

Career Highlights

Ingrid is associated with Behringwerke Aktiengesellschaft, where she continues to advance her research and innovations. Her work has been instrumental in enhancing our understanding of T-cell biology and its applications in medicine.

Collaborations

Ingrid has collaborated with notable colleagues, including Brigitte Biesinger-Zwosta and Bernhard W Fleckenstein. These collaborations have enriched her research and contributed to the success of her projects.

Conclusion

Ingrid Mueller-Fleckenstein's innovative work in the field of immunology exemplifies the impact of scientific research on therapeutic advancements. Her contributions continue to pave the way for future discoveries in T-cell transformation and applications.